Month: April 2025

NOVAGOLD Files First Quarter 2025 Report with Strong Treasury to Advance Donlin Gold Activities for Long-Term Value Creation

Written by Customer Service on April 1, 2025. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) today filed its 2025 first quarter report and provided an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”). Details of the financial results for the quarter ended February 28, 2025, are presented in the consolidated financial statements and quarterly report on Form 10-Q filed on April 1, 2025, that is available on the Company’s website at www.novagold.com, on SEDAR+ at www.sedarplus.ca, and on EDGAR at www.sec.gov. As detailed in the above filings, NOVAGOLD held approximately $93 million in cash and term deposits as of February 28, 2025, and reported net first quarter cash expenditures of $8.3 million — including...

Safe Harbor Financial Reports Fourth Quarter and Year-End 2024 Results

Written by Customer Service on April 1, 2025. Posted in Earnings Releases And Operating Results.

— Adjusted EBITDA(1) is positive for each of the last 3 years; Adjusted Working Capital(2) is approximately positive $2 million — Loan Interest Income increased 82% and 123% year-over-year for the three months and full-year ended December 31, 2024, respectively — Revenue for the Q4 2024 increased 5% compared to the Q3 2024, led by a 35% sequential increase in loan interest income — Loan Loss Reserve of approximately $1.4 million reserved as a result of a modified Commercial Alliance Agreement (CAA) with Partner Colorado Credit Union (PCCU) — Modifications of PCCU Commercial Alliance Agreement and Note enable new CEO Terry Mendez to implement growth strategy offering broader solutions for clients GOLDEN, Colo., April 01, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ:...

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Written by Customer Service on April 1, 2025. Posted in Earnings Releases And Operating Results.

Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe Operating loss decreased by 30% and net loss by 18%, driven by targeted cost reductions and a sharper strategic focus Strategic partnerships with industry leaders mark key progress Company highlights its early accomplishments for 2025 BERKELEY, Calif. and MAINZ, Germany, April 01, 2025 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today financial results for the year ended December 31, 2024, a summary on 2024 accomplishments, and an update on corporate developments for early 2025. Key 2024 AccomplishmentsMainz Biomed and Thermo Fisher Scientific signed a collaboration agreement for the development...

Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program

Written by Customer Service on April 1, 2025. Posted in Mergers And Acquisitions.

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and medical countermeasures, is pleased to announce that further to its press release dated March 3, 2025, it has entered into an asset purchase agreement (the “Agreement”) dated March 31, 2025 with DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) (“DiagnaMed”) to acquire the full rights to DiagnaMed’s intellectual property (the “Acquired Assets”) pertaining to molecular hydrogen as potential treatments for neurological and mental health disorders (the “Acquisition”). Pursuant to the Agreement, the consideration for the Acquired Assets will be satisfied through...

Watsco Declares $3.00 Quarterly Dividend, Reflects 11% Increase to an Annual Rate of $12.00 Per Share

Written by Customer Service on April 1, 2025. Posted in Dividend Reports And Estimates.

MIAMI, April 01, 2025 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $3.00 on each outstanding share of its Common and Class B common stock payable on April 30, 2025 to shareholders of record at the close of business on April 15, 2025. This marks an 11% increase to an annual rate of $12.00 per share. Albert H. Nahmad, Watsco’s Chairman & CEO stated: “We are pleased to increase dividends to shareholders, reflecting our continued confidence in our business, which is fundamentally supported by our strong balance sheet.” Watsco has paid dividends to shareholders for 51 consecutive years. The Company’s philosophy is to share cash flow through dividends while maintaining a conservative balance sheet with continued capacity to build its distribution network. Future...

Dada Enters into Definitive Agreement for “Going Private” Transaction

Written by Customer Service on April 1, 2025. Posted in Mergers And Acquisitions.

SHANGHAI, China, April 01, 2025 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced that it has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with JD Sunflower Investment Limited, a British Virgin Islands company (“Parent”) and JD Sunflower Merger Sub Limited, a Cayman Islands company and a wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the Merger Agreement, Merger Sub will merge with and into the Company, with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the “Merger”). Parent is wholly owned by JD.com, Inc. (“JD”). At the effective time of the Merger (the “Effective Time”), each American Depository Share of the Company (each, an “ADS”),...

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 Per Share for April 2025

Written by Customer Service on April 1, 2025. Posted in Dividend Reports And Estimates.

HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.08 per share for April 2025. This distribution is payable to common stockholders on April 30, 2025 (as outlined in the table below). The Company declares distributions on a monthly basis, with its next distribution expected to be declared in early May. Payment of future distributions is subject to the approval of the Company’s Board of Directors, as well as meeting the covenants on the Company’s debt agreements and the terms of its preferred stock.Record Date / Ex-Date Payment Date Distribution Amount Return of CapitalEstimate4/15/25 4/30/25 $0.08 60%(1)(1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character...

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 31 03 2025] – (CGWL)

Written by Customer Service on April 1, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Form 8.3 – [ALLIANCE PHARMA PLC – 31 03 2025] – (CGWL)

Written by Customer Service on April 1, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

The Board of Directors’ resolution on the issuance of convertible loans

Written by Customer Service on April 1, 2025. Posted in Public Companies.

The Board of Directors’ resolution on the issuance of convertible loans April 1, 2025Announcement no. 4 The Board of Directors of Pharma Equity Group has decided to issue convertible loans in accordance with the authorisation in the Company’s Articles of Association under item 4.3.A. The convertible loans allow Pharma Equity Group to borrow up to DKK 6,757,895. The main terms and conditions for the convertible loans are: The loans are granted as subordinated loan capital and are thus subordinated to the company’s other creditors, except for any other similar subordinated loan capital. The Lender’s right to convert the loans into shares in the Company may be exercised for a period of 30 days commencing 23 calendar months after the conclusion of the convertible loan (the...

Month: April 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals